Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Cell death. Found 2 abstracts

Campbell KS. Genetically modified human natural killer cell lines expressing Fc receptor for assessing efficacy of antibody against cancer or infection. 2006 Jul 08;:90 pp.
Skalka AM, Katz RA, Daniel R. Assays and novel cellular targets for therapeutic agents to treat retroviral infection. 2000 Sep 21;:41 pp.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Cell death

Apoptosis Cell death Equus caballus FcgRII receptors FcaRI receptors Fc receptor expressing NK cell therapeutic antibody efficacy assessment BSU (Biological study Gene Role: BPR (Biological process)-unclassified)-BIOL (Biological study)-PROC (Process) (resistance Felis unclassified) Reagents Role: ARU (Analytical role-BSU (Biological study-unclassified)-BUU (Biological use-unclassified)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (blocking Rattus antibody-dependent Immunity (cell-mediated Bos taurus DNA repair NK-92 Lymphocyte (natural killer cell Cytolysis Avian sarcoma virus Nervous system (ataxia telangiectasia unclassified) Interferons Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (g cDNA sequences (genetically modified human natural killer cell lines expressing Fc receptor for assessing efficacy of antibody against cancer or infection) FcRn receptors genetically modified h BSU (Biological study Antibodies and Immunoglobulins Role: ANT (Analyte)-unclassified)-THU (Therapeutic use)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (efficacy assessment Cytotoxicity Murine leukemia virus Anti-infective agents HeLa cell scid mouse Immunodeficiency (severe combined S7 Hematopoietic precursor cell (B-cell-S29-and S33 cell lines DNA dependent protein kinase virucide screening FceRI receptors unclassified) Immunoglobulin receptors Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-PRP (Properties)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (Fcy Oryctolagus cuniculus BSU (Biological study Antibodies and Immunoglobulins Role: ANT (Analyte)-unclassified)-THU (Therapeutic use)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (chimeric-efficacy assessment BSU (Biological study Antibodies and Immunoglobulins Role: ANT (Analyte)-unclassified)-THU (Therapeutic use)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (fragments-efficacy assessment Immunoglobulin receptors Mutation (ataxia telangiectasia mutated DNA-dependent protein kinase unclassified) Interleukin 2 Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (genetically modified human natural killer cell lines exp Bison bison virucide screening retrovirus infection enzyme target Neoplasm FcgR receptors unclassified) Polynucleotides Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-PRP (Properties)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (genetically modified human natural k Antiviral agents Culture media (supernatant Canidae Human immunodeficiency virus Cytokines Mouse (cell line unclassified) FceRI receptors Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-PRP (Properties)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (g Retroviral vectors (RCAD64Eneo human natural killer cell Fc receptor antibody cancer infection Retroviridae Reporter gene genetically modified human natural killer cell lines expressing Fc receptor for assessing efficacy of antibody against cancer or infection) Infection Affinity (low and high binding form Protein motifs (antigen-binding domain unclassified) Proteins Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (accessory signal Sus scrofa domestica Mustela putorius furo Retroviral vectors BSU (Biological study Viral DNA Role: BPR (Biological process)-unclassified)-BIOL (Biological study)-PROC (Process) (assays and cellular targets for therapeutic agents to treat retroviral infection) FcgRIIIa receptors Drug screening unclassified) TCR Role: ARU (Analytical role-BPN (Biosynthetic preparation)-BSU (Biological study-unclassified)-PRP (Properties)-ANST (Analytical study)-BIOL (Biological study)-PREP (Preparation) (z FcgRIII receptors Enzymes Hybridoma Lama pacos FcgRI receptors BSU (Biological study Gene Role: BPR (Biological process)-unclassified)-BIOL (Biological study)-PROC (Process) (neo Antitumor agents (antibody Poultry Retroviral vectors (RCA8KSneo Animal cell line BSU (Biological study Antibodies and Immunoglobulins Role: ANT (Analyte)-unclassified)-THU (Therapeutic use)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (monoclonal-efficacy assessment Protein sequences Human Test kits (assays and cellular targets for therapeutic agents to treat retroviral infection) BSU (Biological study Antibodies and Immunoglobulins Role: ANT (Analyte)-unclassified)-THU (Therapeutic use)-ANST (Analytical study)-BIOL (Biological study)-USES (Uses) (polyclonal-efficacy assessment Mus musculus Recombination (integration Molecular cloning assays and cellular targets for therapeutic agents to treat retroviral infection) man natural killer cell lines expressing Fc receptor for assessing efficacy of antibody against cancer or infection)
Last updated on Thursday, August 06, 2020